PCMVX
Price
$15.40
Change
-$0.01 (-0.06%)
Updated
Jun 5 closing price
Net Assets
2.42B
VMVIX
Price
$63.54
Change
-$0.14 (-0.22%)
Updated
Jun 5 closing price
Net Assets
29.95B
Interact to see
Advertisement

PCMVX vs VMVIX

Header iconPCMVX vs VMVIX Comparison
Open Charts PCMVX vs VMVIXBanner chart's image
Principal MidCap Value I A
Price$15.40
Change-$0.01 (-0.06%)
VolumeN/A
Net Assets2.42B
Vanguard Mid-Cap Value Index Investor
Price$63.54
Change-$0.14 (-0.22%)
VolumeN/A
Net Assets29.95B
PCMVX vs VMVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PCMVX vs. VMVIX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCMVX is a Buy and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 29.9B vs. PCMVX (2.42B). VMVIX pays higher dividends than PCMVX: VMVIX (2.19) vs PCMVX (1.08). PCMVX was incepted earlier than VMVIX: PCMVX (6 years) vs VMVIX (19 years). PCMVX (1.09) is less costly to investors than VMVIX (0.19). PCMVX is a more actively managed with annual turnover of: 55.30 vs. VMVIX (19.00). PCMVX has a lower initial minimum investment than VMVIX: PCMVX (1000) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 6.37 vs. PCMVX (-9.80). VMVIX return over 5 years is better than : 56.64 vs. PCMVX (22.46).
PCMVXVMVIXPCMVX / VMVIX
Total Expense Ratio1.070.19563%
Annual Report Gross Expense Ratio1.090.19574%
Fund Existence6 years19 years-
Gain YTD-0.5810.042-1,375%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets2.42B29.9B8%
Annual Yield % from dividends1.082.1949%
Returns for 1 year-9.806.37-154%
Returns for 3 years-7.7512.79-61%
Returns for 5 years22.4656.6440%
Returns for 10 yearsN/A79.97-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDECX21.76N/A
N/A
Fidelity Advisor Capital Development C
PJHRX29.20N/A
N/A
PGIM Jennison Health Sciences R
IVITX22.44N/A
N/A
VY® Invesco Growth and Income S2
RBCRX9.80N/A
N/A
RBC China Equity R6
HESAX41.79N/A
N/A
Horizon Defensive Core Advisor